-75%

est. 2Y upside i

HealthcareProductivity

We are making a HIPAA-compliant, Groupme app for doctors to…

Rank

#2600

Sector

Healthcare Technology, Clinical Communication and Collaboration

Est. Liquidity

~4Y

Data Quality

Data: Low

The equity opportunity at Medigram is highly speculative due to very limited funding and intense competition from established players, but offers potential upside if its specialized AI trust infrastructure gains significant market traction and leads to a strategic acquisition.

Last updated: February 16, 2026

Bull (15%)+250%

Medigram successfully differentiates its AI trust infrastructure, secures significant partnerships, and is acquired by a major healthcare tech player at a premium.

Base (40%)+100%

Medigram gains moderate traction in its niche, achieving sustainable revenue, and is acquired by a smaller strategic buyer for its technology and customer base.

Bear (45%)-95%

Medigram struggles to compete with well-funded incumbents, fails to secure additional funding, or its AI trust infrastructure doesn't gain sufficient market adoption, leading to a low-value acquisition or closure.

Est. time to liquidity~4.0 years

Community

Valuation Sentiment

Our model estimates -75% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.